These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3197819)

  • 1. Hypocholesterolemia in acute myelogenous leukemia.
    Reverter JC; Sierra J; Martí-Tutusaus JM; Montserrat E; Grañena A; Rozman C
    Eur J Haematol; 1988 Oct; 41(4):317-20. PubMed ID: 3197819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relation between hypocholesterolemia and degree of maturation in acute myeloid leukemia.
    Zyada LE; Hassan HT; Rees JK; Ragab MH
    Hematol Oncol; 1990; 8(1):65-9. PubMed ID: 2298420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypocholesterolemia and acute myelogenous leukemia. Association between disease activity and plasma low-density lipoprotein cholesterol concentrations.
    Budd D; Ginsberg H
    Cancer; 1986 Sep; 58(6):1361-5. PubMed ID: 3461875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol catabolism in patients with acute myelogenous leukemia and hypocholesterolemia: suppressed levels of a circulating marker for bile acid synthesis.
    Tatidis L; Vitols S; Gruber A; Paul C; Axelson M
    Cancer Lett; 2001 Sep; 170(2):169-75. PubMed ID: 11463495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypocholesterolemia as a manifestation of disease activity in chronic myelocytic leukemia.
    Gilbert HS; Ginsberg H
    Cancer; 1983 Apr; 51(8):1428-33. PubMed ID: 6572087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute myelomonocytic leukemia: an unusual variant with both granulocytic and monocytic esterases in the leukemic cells.
    Li CY; Phyliky RL; Yam LT
    Mayo Clin Proc; 1986 Feb; 61(2):104-9. PubMed ID: 3456074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification of acute non-lymphocytic leukemia according to the distribution picture of peroxidase activity and cell size: correlation between the classification and therapeutic response.
    Takubo T; Kubota Y; Oguma S; Ueda T; Shibata H; Nakamura H; Masaoka T; Yoshitake J; Ishigami S
    Blood Cells; 1983; 9(3):501-14. PubMed ID: 6586210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of Auer rods in childhood acute myelogenous leukemia: results of the studies AML-BFM-78 and -83.
    Ritter J; Vormoor J; Creutzig U; Schellong G
    Med Pediatr Oncol; 1989; 17(3):202-9. PubMed ID: 2546027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypocholesterolemia and acute myeloid leukemia (AML).
    Porta C; Moroni M; Nastasi G; Invernizzi R; Bobbio-Pallavicini E
    Haematologica; 1991; 76(4):348. PubMed ID: 1794744
    [No Abstract]   [Full Text] [Related]  

  • 10. Disease-related hypocholesterolemia in patients with hairy cell leukemia. Positive correlation with spleen size but not with tumor cell burden or low density lipoprotein receptor activity.
    Juliusson G; Vitols S; Liliemark J
    Cancer; 1995 Aug; 76(3):423-8. PubMed ID: 8625123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multivariate analysis of factors associated with outcome of treatment for adults with acute myelogenous leukemia.
    Schwartz RS; Mackintosh FR; Halpern J; Schrier SL; Greenberg PL
    Cancer; 1984 Oct; 54(8):1672-81. PubMed ID: 6592033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Childhood acute myeloblastic leukemias. Report of 21 cases].
    Laatiri MA; Chehata S; Amouri A; Bouaouina N; Chatti S; Saad A; Ennabli S
    Tunis Med; 2000 Mar; 78(3):167-71. PubMed ID: 11026819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Toxicity of different treatment protocols for acute myeloid leukemias in adults: the results of four Russian multicenter studies].
    Parovichnikova EN; Savchenko VG; Kliasova GA; Isaev VG; Sokolov AN; Kulikov SM; Ustinova EN; Gribanova EO; Ryzhko VV; Khoroshko ND; Kravchenko SK; Galstian GM; Konstantinova TS; Zagoskina TP; Ziuzgin IS; Kaplanov KD; Moskov VI; Sokolova IV; Anchukova LV; Lapin VA; Loginov AB; Tumakov VA; Korobkin AV; Miliutina GI; Samoĭlova OS; Tikunova TS; Pristupa AS; Kondakova EV; Domnikova NP; Gavrilova LV; Obidina NA; Porokhina OV; Rekhtman GB; Mashchuk VN; Khuazheva NK; Kaporskaia TS; Golubeva ME; Maksimov AG; Ploskikh MA; Men'shakova SN; Mal'tsev VI; Rossiev VA; Pilipenko GI
    Ter Arkh; 2010; 82(7):5-11. PubMed ID: 20853602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between white blood cell count elevation and clinical response after G-CSF priming chemotherapy for acute myeloid leukemia.
    Minakata D; Fujiwara SI; Ikeda T; Toda Y; Ito S; Mashima K; Umino K; Nakano H; Yamasaki R; Morita K; Kawasaki Y; Sugimoto M; Yamamoto C; Ashizawa M; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Kanda Y
    Int J Hematol; 2017 Sep; 106(3):411-417. PubMed ID: 28508228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in childhood acute myelogenous leukemia.
    Grier HE; Gelber RD; Camitta BM; Delorey MJ; Link MP; Price KN; Leavitt PR; Weinstein HJ
    J Clin Oncol; 1987 Jul; 5(7):1026-32. PubMed ID: 3474356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of cytogenetic analyses in patients with acute nonlymphocytic leukemia treated with the same intensive chemotherapy.
    Tashiro S; Kyo T; Tanaka K; Oguma N; Hashimoto T; Dohy H; Kamada N
    Cancer; 1992 Dec; 70(12):2809-15. PubMed ID: 1451059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of blood and marrow findings in acute myelogenous leukemia in remission. A Southeastern Cancer Study Group report.
    Vogler WR; Raney MR
    Cancer; 1988 Jun; 61(12):2481-6. PubMed ID: 3163256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlative patterns of leukocyte counts at presentation and relapse in acute myelogenous leukemia.
    Schwartz RS; MacKintosh FR; Greenberg PL
    Acta Haematol; 1986; 75(2):79-82. PubMed ID: 3090826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Large granule-containing lymphocytes in patients with acute leukemia].
    Gashchuk AP; Kindzel'skiĭ AL
    Vrach Delo; 1989 Jul; (7):10-1. PubMed ID: 2800475
    [No Abstract]   [Full Text] [Related]  

  • 20. [The first Russian trial of treating patients with acute nonlymphoblastic leukemias with novantrone combined with cytosar].
    Volkova MA; Kaletin GI
    Ter Arkh; 1992; 64(7):18-21. PubMed ID: 1440359
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.